« Back
Home /
Auranofin

Auranofin

Manufacturer	MedChem Express
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Colorectal Cancer Testicular & Prostate Cancer
Type	Inhibitors
Specific against	other
Amount	10mM/1mL
Item no.	HY-B1123-10mM
CASRN	34031-32-8
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Auranofin (SKF-39162) is a thioredoxin reductase (TrxR) inhibitor with an IC50 of 0.2 μM. Auranofin exhibits antiviral activity against SARS-CoV21, with a CC50 of 4.2 μM for monkey kidney Vero E6 cells.
StorageTemperature	4°C (Powder, sealed storage, away from moisture)
Shipping	Room Temperature
Manufacturers Applications	COVID-19-immunoregulation
MolecularWeight	680.50
Clinical_Information	Launched
Manufacturers Research_Area	Cancer; Infection; Inflammation/Immunology
Solubility	DMSO : 50 mg/mL (ultrasonic)
Manufacturers Target	Bacterial; SARS-CoV
Pathway	Anti-infection
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-B1123-10mM-safety-datasheet.pdf